[1] Alani RM, Munger K. Human papillomavirus and associated malignancies[J]. J Clin Oncol, 1998, 16(1): 330-7. [2] Chen Z, Kamath P, Zhang S, et al. Efeects on tumor cells ofribozymes that cleave the RNA transcripts of human papillomavius type 18 [J].Cancer Gene Therapy, 1996, 3(1): 18-23. [3] Zheng YF, Zhang J R, Qu L H, et al. Effectiveness ofa ribozyme for cleavage of an RNA transcript from human papillomavirus type 16 [J]. Int J Modern Cancer Ther, 1998, 1(1): 134-8. [4] 郑燕芳,饶智国,张积仁.抗HPV16E6核酶对宫颈癌细胞恶性表型的影响[J].中国肿瘤生物治疗杂志,2002,9(3):183-5.Zheng YF, Rao ZG, Zhang JR. The effect ofAnti-HPV16 E6-ribozyme on malignant phenotypes of cervical carcinoma cell line.Chin J Cancer Biother, 2002, 9(3): 183-5. [5] 郑燕芳,张积仁,屈良鹄,等.抗HPVE6核酶的原核表达与体外活性研究[J].中华微生物与免疫学杂志,2000,20(1):79-82.Zheng YF, Zhang JR, Qu LH, et al. The study ofanti-HPV16E6 ribozyme, expression and cleavage in vitro [J]. Chin J Microbiol Immunol, 2000, 20(1): 79-82. [6] Ueda M, Terai Y, Yamashita Y, et al. Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas[J]. Int J Cancer, 2002, 98(3): 335-43. [7] 饶智国,张积仁,郑燕芳,等.抗HPV16E6核酶对宫颈癌CaSKi细胞化疗的影响[J].第一军医大学学报,2002,22(4):316-9.Rao ZG, Zhang JR, Zheng YF, et al. Effect of anti-HPV16 E6-ribozyme on the sensitivity of cervical carcinoma cell line to chemotherapy [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 22(4): 316-9. [8] 周忠江,刘伊丽,吴平生,等.带信号肽人血管内皮生长因子基因VEGF121及VEGF165载体的克隆[J].第一军医大学学报,2002,22(2):111-3.Zhou ZJ, Liu YL, Wu PS, et al. Cloning of expression vector for VEGF121 and VEGF165 genesn human vascular endothelial growth factor [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2002, 22(2): 111-3. |